U.S., July 21 -- ClinicalTrials.gov registry received information related to the study (NCT07714772) titled 'A Study of Dimdazenil in Patients With Parkinson's Disease and Insomnia' on July 01.
Brief Summary: This study will use sleep parameters measured by polysomnography (PSG) as the primary means to evaluate the efficacy and safety of dimdazenil, a GABAA receptor partial agonist, in treating insomnia in Parkinson's disease patients.
Study Start Date: Aug. 01
Study Type: OBSERVATIONAL
Condition:
Insomnia
Parkinson's Disease (PD)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Second Affiliated Hospital of Soochow University
Published by HT Digital Content Services with permission from Health Daily Digest....